 "Q1 results, Q1 earnings")
Drug firm Sanofi India on Thursday said its net profit increased by 2.5 per cent to Rs 123 crore for the second quarter ended on June 30, 2023.
The company reported a net profit of Rs 120 crore in the April-June quarter of last year.
Revenue from operations rose to Rs 706 crore in the period under review from Rs 699 crore in the same period last year, Sanofi India said in a regulatory filing.
The company follows a January-December financial year.
"The company has delivered a strong second quarter performance despite the National List of Essential Medicines (NLEM) impact," Sanofi India Managing Director Rodolfo Hrosz said.
The company will continue to focus on driving further improvement in operating efficiencies while expanding the availability of its established and innovative products in India, he added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
